JUL 20, 2026 · JOURNAL ARTICLE
Bis-(di-4-phenyl-benzylaminethiocarbonyl)disulfide sensitizes ABCC2/ALDH3A1 overexpressing NSCLC cells to cisplatin.
Cancer Biology & Therapy
In vitro study demonstrates reversal of cisplatin resistance in one cell line via ALDH and ABCC2 inhibition, requiring validation in additional models and clinical testing.
Reported
Patient subgroup thresholdZ-score > 1.5